Table 1.
Patient characteristics (n = 31)
| Age | years |
| Mean | 58.48 |
| Range | 41‐77 |
| Sex | n (%) |
| Male | 15 (48.4%) |
| Female | 16 (51.6%) |
| ECOG performance status | n (%) |
| 0 | 21 (67.7%) |
| 1 | 8 (25.8%) |
| 2 | 2 (6.5%) |
| KRAS status | n (%) |
| Mutation | 15 (48.4%) |
| Wild type | 4 (12.9%) |
| Unknown | 12 (38.7%) |
| Diagnosis | n (%) |
| Lung cancer | 16 (51.6%) |
| Adenocarcinoma | 15 (48.4%) |
| Mixed type | 1 (3.2%) |
| Colorectal cancer | 3 (9.7%) |
| Malignant melanoma | 3 (9.7%) |
| Ovarian cancer | 2 (6.5%) |
| Breast cancer | 1 (3.2%) |
| Oesophageal cancer | 1 (3.2%) |
| Pancreatic cancer | 1 (3.2%) |
| Vaginal cancer | 1 (3.2%) |
| Hemagiopericytoma | 1 (3.2%) |
| Leiomyosarcoma | 1 (3.2%) |
| CUP | 1 (3.2%) |
| Previous treatments | median (range) |
| Surgery | 1 (0‐4) |
| Radiation | 1 (0‐4) |
| Chemotherapy | 2.5 (0‐6) |
| Targeted therapy | 0 (0‐2) |